Trials / Recruiting
RecruitingNCT07271043
Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Type 2 Diabetes Patients Treated With Incretin Mimetics
Evaluating the Efficacy of High-Protein Diabetes Specific Formula (HP-DSF) on Body Composition in Overweight/Obese Patients With Type 2 Diabetes Treated With Incretin Mimetic Drugs
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Joslin Diabetes Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A randomized clinical study to assess the efficacy of a high-protein diabetes specific formula (HPDSF) on lean muscle mass in overweight and obese patients with type 2 diabetes who are initiating treatment with incretin-mimetic drugs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | protein supplement | HP-DSF shakes (Protality Base or Ensure Max Protein by Abbott Nutrition) |
Timeline
- Start date
- 2026-01-01
- Primary completion
- 2026-11-01
- Completion
- 2026-12-01
- First posted
- 2025-12-08
- Last updated
- 2026-01-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07271043. Inclusion in this directory is not an endorsement.